Related Experiment Video

Updated: Oct 12, 2025

Mass Cytometry Analysis of Systemic and Local Immune Responses in Hepatocellular Carcinoma
08:25

Mass Cytometry Analysis of Systemic and Local Immune Responses in Hepatocellular Carcinoma

Published on: April 25, 2025

335

[Regulatory effect of molecular targeted drugs on the immune system for liver cancer]

X Cheng1, J Z Chen1, Y B Guo1

  • 1Department of Infectious Diseases, Nanfang Hospital of Southern Medical University, Guangzhou 510515, China.

Zhonghua Gan Zang Bing Za Zhi = Zhonghua Ganzangbing Zazhi = Chinese Journal of Hepatology
|November 24, 2021
PubMed

Insights

Molecular targeted drugs and immunotherapy are key for liver cancer. Combining targeted therapies with immunotherapy shows promise for advanced liver cancer treatment, improving outcomes beyond single-agent approaches.

Area of Science:

  • Hepatocellular carcinoma research
  • Cancer immunotherapy
  • Molecular targeted therapy

Background:

  • Molecular targeted drugs are primary systemic treatments for liver cancer, with several approved in the last decade.
  • Immunotherapy, including nivolumab and pembrolizumab, is now a significant option for advanced hepatocellular carcinoma (HCC) after sorafenib treatment.
  • Single-agent therapies often yield unsatisfactory results in advanced liver cancer.

Purpose of the Study:

  • To review the immunomodulatory effects of molecular targeted drugs in liver cancer.
  • To explore the potential of combining targeted therapy with immunotherapy for advanced HCC.
  • To highlight emerging treatment strategies in liver cancer systemic therapy.

Main Methods:

  • Literature review of studies on molecular targeted drugs in liver cancer.
  • Analysis of clinical trial data for targeted therapies and immunotherapies.
  • Examination of evidence on the immunomodulatory roles of targeted agents.

Main Results:

  • Molecular targeted drugs possess significant immunomodulatory capabilities in liver cancer.
  • Combination therapies of targeted drugs and immunotherapy demonstrate promising clinical efficacy.
  • Evidence suggests synergistic effects between targeted agents and immune checkpoint inhibitors.

Conclusions:

  • Targeted therapies can enhance the effectiveness of immunotherapy in liver cancer.
  • Combined approaches offer a more potent strategy for managing advanced HCC.
  • Further research into targeted drug immunomodulation is crucial for optimizing liver cancer treatment.
Keywords:
ImmunoloregulationImmunotherapyLiver cancerTargeted therapy

More Related Videos

An Oncogenic Hepatocyte-Induced Orthotopic Mouse Model of Hepatocellular Cancer Arising in the Setting of Hepatic Inflammation and Fibrosis06:38

An Oncogenic Hepatocyte-Induced Orthotopic Mouse Model of Hepatocellular Cancer Arising in the Setting of Hepatic Inflammation and Fibrosis

Published on: September 12, 2019

9.1K
Advances in Human Induced Pluripotent Stem Cell-Derived Chimeric Antigen Receptor-Expressing Natural Killer Cells11:08

Advances in Human Induced Pluripotent Stem Cell-Derived Chimeric Antigen Receptor-Expressing Natural Killer Cells

Published on: February 14, 2025

1.2K

Related Concept Videos

Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
7.9K
Tumor Immunotherapy01:27

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
725
Combination Therapies and Personalized Medicine02:50

Combination Therapies and Personalized Medicine

Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
5.2K
Cytotoxic T Cells-mediated Immune Response01:27

Cytotoxic T Cells-mediated Immune Response

Cytotoxic T cells are a vital component of the immune system. They have the remarkable ability to identify and target antigens on infected or abnormal cells. These antigens often originate from intracellular pathogens such as viruses or abnormal proteins cancer cells produce.
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
4.3K
Effect of Hepatic Disease on Pharmacokinetics: Drug Dosing and Hepatic Blood Flow01:26

Effect of Hepatic Disease on Pharmacokinetics: Drug Dosing and Hepatic Blood Flow

Chronic liver disease significantly impacts drug metabolism due to alterations in hepatic blood flow and enzyme accessibility. This disruption affects the body's pharmacokinetics—the movement and processing of drugs within the system. Key enzymes crucial for metabolizing medications become less accessible, changing how drugs are processed and utilized. Furthermore, liver disease influences the synthesis of plasma proteins, such as albumin and globulins, which play critical roles in drug...
21
Cancer Therapies02:49

Cancer Therapies

Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
8.1K